TJM Labs launches Vaccine Bot for pharmacies ahead of flu season

TJM Labs on July 16, 2026 introduced Vaccine Bot, an AI agent that automates vaccine prescription entry after pharmacist review. The rollout expands the company’s pharmacy AI platform as pharmacies prepare for vaccine season and look to reduce admin work while serving more patients.

Why it matters: - Vaccine Bot is designed to reduce the administrative burden tied to pharmacy vaccinations during the busiest vaccine season. - The product keeps pharmacists in control of clinical decisions while automating a time-consuming data entry step. - TJM Labs is positioning the launch as part of a broader effort to expand pharmacy capacity without adding manual work.

What happened: - TJM Labs announced Vaccine Bot on July 16, 2026. - The AI agent automatically enters vaccination information into the pharmacy management system after pharmacist review and approval. - The launch comes ahead of vaccine season. - TJM Labs said a limited number of pharmacies will participate in the initial rollout. - The company is directing pharmacies to request a demo to learn more about Vaccine Bot.

The details: - Patients enter vaccination information on an in-store iPad or a secure mobile link. - The intake includes demographic information, insurance details, and requested vaccines. - After pharmacist review, edit, and approval, Vaccine Bot submits the prescription into the pharmacy management system. - The agent then initiates the pharmacy’s existing workflow. - Vaccine Bot supports multiple vaccines during a single visit. - The system transfers patient information over encrypted connections. - The product retries submissions if a pharmacy workstation is temporarily unavailable. - TJM Labs said no vaccination records are lost during that retry process. - The technology performs no clinical decision-making. - Pharmacists review and approve every vaccination before automation begins. - Vaccine Bot was built by pharmacists and engineers working together, according to the company.

Between the lines: - Vaccine Bot expands TJM Labs’ platform beyond prescription intake, data entry, refills, prior authorization support, and patient communication. - The company says its AI agents already automate repetitive operational workflows across more than 450 pharmacies. - The product integrates with TJM Labs’ existing Retail Bot platform, which lets current customers activate the capability without buying new hardware or going through complex implementation. - The usage-based pricing model is set at $1 per vaccine prescription entered. - TJM Labs is betting pharmacies want a broader AI platform rather than a single-purpose tool. - Jonathan Adly, the company’s founder and CEO, said the goal is to automate operational work surrounding patient care, not clinical decisions.

What’s next: - TJM Labs expects the initial rollout to be limited before broader adoption. - Pharmacies interested in the product can contact TJM Labs for a demo ahead of vaccine season. - The company said Vaccine Bot is another step toward its vision of an AI workforce for pharmacy across major operational processes. - TJM Labs says its AI agents handle more than 500,000 pharmacy tasks every day across 450+ pharmacies. - The company says it has raised $100 million and acquired EncoreRx and Pharmesol as it consolidates pharmacy AI into a single platform.

The bottom line: - Vaccine Bot is TJM Labs’ latest bid to turn pharmacy vaccination work into a faster, more automated workflow while keeping pharmacists in charge of final approval.